Carl Guévin
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- Hepatitis C virus research 3
- Surgery 2
- Lipoproteins and Cardiovascular Health 1
- Cholesterol and Lipid Metabolism 1
- Co-authors
- Patrick Labonté (4 shared papers)Vincent Pichette (2 shared papers)Isabelle Pellerin (1 shared paper)Christian Demers (1 shared paper)Marielle Gascon‐Barré (1 shared paper)Kouacou V. Konan (1 shared paper)Nabil G. Seidah (2 shared papers)Paul Mak (1 shared paper)
- Journals
- Antiviral Research (2 papers)Virology (1 paper)British Journal of Pharmacology (1 paper)Hepatology (1 paper)Journal of the American Society of Nephrology (1 paper)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Carl Guévin
6 papers receiving 555 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 99
- Hepatology 74
- Transplantation 16
- Pediatrics, Perinatology and Child Health 84
- Nephrology 32
Countries citing papers authored by Carl Guévin
This map shows the geographic impact of Carl Guévin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Guévin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Guévin more than expected).
Fields of papers citing papers by Carl Guévin
This network shows the impact of papers produced by Carl Guévin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Guévin. The network helps show where Carl Guévin may publish in the future.
Co-authors
The 18 scholars most cited alongside Carl Guévin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 176 | |
| 2 | 2010 | 134 | |
| 3 | 2009 | 125 | |
| 4 | 2002 | 91 | |
| 5 | 2015 | 32 | |
| 6 | 2009 | 12 |
About Carl Guévin
Carl Guévin is a scholar working on Hepatology, Surgery, Epidemiology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 6 papers that have together received 570 indexed citations. Recurring topics across this work include Hepatitis C virus research (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Lipoproteins and Cardiovascular Health (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Cholesterol and Lipid Metabolism (1 paper), Autophagy in Disease and Therapy (1 paper) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Pharmacology (99 citations), Hepatology (74 citations), Transplantation (16 citations), Pediatrics, Perinatology and Child Health (84 citations) and Nephrology (32 citations). Carl Guévin has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Patrick Labonté, Vincent Pichette, Isabelle Pellerin, Christian Demers, Marielle Gascon‐Barré, Kouacou V. Konan, Nabil G. Seidah, Paul Mak, Josée Michaud and François A. Leblond. Their work appears in journals such as Antiviral Research, Virology, British Journal of Pharmacology, Hepatology and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.